Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

A clinical trial of Fluosol DA 20% in advanced squamous cell carcinoma of the head and neck.

Rose C, Lustig R, McIntosh N, Teicher B.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1325-7.

PMID:
3759553
2.

Phase I/II study of Fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck.

Lustig R, McIntosh-Lowe N, Rose C, Haas J, Krasnow S, Spaulding M, Prosnitz L.

Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1587-93.

PMID:
2722598
3.

Fluosol DA and oxygen as an adjuvant to the radiotherapeutic management of advanced head/neck carcinoma.

Lustig RA, Rose CM, McIntosh-Lowe NL.

Biomater Artif Cells Artif Organs. 1988;16(1-3):511-8. No abstract available.

PMID:
3179488
4.

Treatment-related toxicities with Fluosol-DA 20% infusion during radiation in advanced head and neck malignancies.

Campbell BH, Janjan NA, Byhardt RW, Toohill RJ.

Laryngoscope. 1990 Mar;100(3):237-9.

PMID:
2407916
5.

Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.

Rockwell S, Mate TP, Irvin CG, Nierenburg M.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1315-8.

PMID:
3093416
6.
7.

Radiosensitization of murine tumors by Fluosol-DA 20%.

Lee I, Levitt SH, Song CW.

Radiat Res. 1990 Jun;122(3):275-9.

PMID:
2113298
8.

Therapeutic effect of infused Fluosol-DA/carbogen with ephedrine, flunarizine, or nitroprusside.

Teicher BA, Holden SA, Northey D, Dewhirst MW, Herman TS.

Int J Radiat Oncol Biol Phys. 1993 Apr 30;26(1):103-9.

PMID:
8482616
9.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
10.

[SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].

Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A.

Otolaryngol Pol. 2011 Sep;65(5 Suppl):117-25. Polish.

PMID:
22000261
11.

Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: results of a phase I/II study.

Lustig R, Lowe N, Prosnitz L, Spaulding M, Cohen M, Stitt J, Brannon R.

Int J Radiat Oncol Biol Phys. 1990 Jul;19(1):97-102.

PMID:
2166021
12.

Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III-IV squamous cancers of the head and neck.

Fazekas J, Pajak TF, Wasserman T, Marcial V, Davis L, Kramer S, Rotman M, Stetz J.

Int J Radiat Oncol Biol Phys. 1987 Aug;13(8):1155-60.

PMID:
3301758
13.

Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3rd, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Hartsell W, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Niell HB.

Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):263-71.

PMID:
9226312
14.

Lack of complications in long-term survivors after treatment with Fluosol and oxygen as an adjuvant to radiation therapy for high-grade brain tumors.

Evans RG, Kimler BF, Morantz RA, Batnitzky S.

Int J Radiat Oncol Biol Phys. 1993 Jul 15;26(4):649-52.

PMID:
8330996
15.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
16.

Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.

MacKenzie R, Balogh J, Choo R, Franssen E.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):589-95.

PMID:
10524410
17.

Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.

Lee I, Levitt SH, Song CW.

Radiat Res. 1987 Oct;112(1):173-82.

PMID:
3116597
18.

Irradiation with misonidazole and hyperbaric oxygen: final report on a randomized trial in advanced head and neck cancer.

Sealy R, Cridland S, Barry L, Norris R.

Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1343-6.

PMID:
3531113
19.

Normobaric oxygen as a sensitizer in radiotherapy for advanced head and neck cancer.

Zajusz A, Maciejewski B, Hliniak A.

Neoplasma. 1995;42(3):137-40.

PMID:
7637824
20.

Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.

Bucci MK, Rosenthal DI, Hershock D, Metz J, Devine P, Kligerman MM, Machtay M.

Am J Clin Oncol. 2004 Dec;27(6):595-602.

PMID:
15577438

Supplemental Content

Support Center